# OnCo record paper-empower-cscc-1-cemiplimab-migden-nejm-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-empower-cscc-1-cemiplimab-migden-nejm-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-empower-cscc-1-cemiplimab-migden-nejm-2018" ;
  schema:name "PD-1 blockade with cemiplimab in advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1)"@en ;
  schema:description "Cemiplimab shrank tumours in about half of patients with metastatic or locally advanced cutaneous squamous cell carcinoma, a highly mutated skin cancer with almost no previous treatment options, leading to the first approval for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-empower-cscc-1-cemiplimab-migden-nejm-2018/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1805131>, <https://pubmed.ncbi.nlm.nih.gov/29863979/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1805131> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Migden MR, Rischin D, Schmults CD, et al." ;
  onco:cancers <https://onco.cc/cancers/lip-cancer/>, <https://onco.cc/cancers/advanced-cutaneous-scc/> ;
  onco:drugs <https://onco.cc/drugs/cemiplimab/> ;
  onco:trials <https://onco.cc/trials/empower-cscc-1/> ;
  onco:journals <https://onco.cc/journals/nejm/> .